Progression from external pilot to definitive randomised controlled trial: a methodological review of progression criteria reporting

被引:16
|
作者
Mellor, Katie [1 ]
Eddy, Saskia [2 ]
Peckham, Nicholas [1 ]
Bond, Christine M. [3 ]
Campbell, Michael J. [4 ]
Lancaster, Gillian A. [5 ,6 ]
Thabane, Lehana [7 ]
Eldridge, Sandra M. [2 ]
Dutton, Susan J. [1 ]
Hopewell, Sally [1 ]
机构
[1] Univ Oxford, Ctr Stat Med, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, England
[2] Queen Mary Univ London, Barts & London Sch Med & Dent, Inst Populat Hlth Sci, London, England
[3] Univ Aberdeen, Inst Appl Hlth Sci, Aberdeen, Scotland
[4] Univ Sheffield, Sch Hlth & Related Res, Sheffield, S Yorkshire, England
[5] Keele Univ, Sch Med, Keele, Staffs, England
[6] Keele Univ, Keele Clin Trials Unit CTU, Keele, Staffs, England
[7] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada
来源
BMJ OPEN | 2021年 / 11卷 / 06期
基金
英国医学研究理事会;
关键词
statistics & research methods; protocols & guidelines; clinical trials;
D O I
10.1136/bmjopen-2020-048178
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives Prespecified progression criteria can inform the decision to progress from an external randomised pilot trial to a definitive randomised controlled trial. We assessed the characteristics of progression criteria reported in external randomised pilot trial protocols and results publications, including whether progression criteria were specified a priori and mentioned in prepublication peer reviewer reports. Study design Methodological review. Methods We searched four journals through PubMed: British Medical Journal Open, Pilot and Feasibility Studies, Trials and Public Library of Science One. Eligible publications reported external randomised pilot trial protocols or results, were published between January 2018 and December 2019 and reported progression criteria. We double data extracted 25% of the included publications. Here we report the progression criteria characteristics. Results We included 160 publications (123 protocols and 37 completed trials). Recruitment and retention were the most frequent indicators contributing to progression criteria. Progression criteria were mostly reported as distinct thresholds (eg, achieving a specific target; 133/160, 83%). Less than a third of the planned and completed pilot trials that included qualitative research reported how these findings would contribute towards progression criteria (34/108, 31%). The publications seldom stated who established the progression criteria (12/160, 7.5%) or provided rationale or justification for progression criteria (44/160, 28%). Most completed pilot trials reported the intention to proceed to a definitive trial (30/37, 81%), but less than half strictly met all of their progression criteria (17/37, 46%). Prepublication peer reviewer reports were available for 153/160 publications (96%). Peer reviewer reports for 86/153 (56%) publications mentioned progression criteria, with peer reviewers of 35 publications commenting that progression criteria appeared not to be specified. Conclusions Many external randomised pilot trial publications did not adequately report or propose prespecified progression criteria to inform whether to proceed to a future definitive randomised controlled trial.
引用
收藏
页数:12
相关论文
共 23 条
  • [21] Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal carcinoma treatment (ICON8): primary progression free survival analysis results from a GCIG phase 3 randomised controlled trial
    Clamp, Andrew R.
    James, Elizabeth C.
    McNeish, Iain A.
    Dean, Andrew
    Kim, Jae-Weon
    O'Donnell, Dearbhaile M.
    Hook, Jane
    Coyle, Christopher
    Blagden, Sarah
    Brenton, James D.
    Naik, Raj
    Perren, Tim
    Sundar, Sudha
    Cook, Adrian D.
    Gopalakrishnan, Gosala S.
    Gabra, Hani
    Lord, Rosemary
    Dark, Graham
    Earl, Helena M.
    Hall, Marcia
    Banerjee, Susana
    Glasspool, Rosalind M.
    Jones, Rachel
    Williams, Sarah
    Swart, Ann Marie
    Stenning, Sally
    Parmar, Mahesh
    Kaplan, Richard
    Ledermann, Jonathan A.
    LANCET, 2019, 394 (10214) : 2084 - 2095
  • [22] The acceptability of emergency cervical cerclage within a randomised controlled trial for cervical dilatation with exposed membranes at 16-27+6 weeks gestation: Findings from a qualitative process evaluation of the C-STICH2 pilot trial
    Molloy, Eleanor
    Pilarski, Nicole
    Morris, Katie
    Hodgetts-Morton, Victoria
    Jones, Laura
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2022, 279 : 27 - 39
  • [23] The added value of health-related quality of life as a prognostic indicator of overall survival and progression-free survival in glioma patients: a meta-analysis based on individual patient data from randomised controlled trials
    Coomans, Marijke
    Dirven, Linda
    Aaronson, Neil K.
    Baumert, Brigitta G.
    van den Bent, Martin
    Bottomley, Andrew
    Brandes, Alba A.
    Chinot, Olivier
    Coens, Corneel
    Gorlia, Thierry
    Herrlinger, Ulrich
    Keime-Guibert, Florence
    Malmstrom, Annika
    Martinelli, Francesca
    Stupp, Roger
    Talacchi, Andrea
    Weller, Michael
    Wick, Wolfgang
    Reijneveld, Jaap C.
    Taphoorn, Martin J. B.
    EUROPEAN JOURNAL OF CANCER, 2019, 116 : 190 - 198